Rhythm Pharmaceuticals, Inc. Common Stock RYTM
$104.71
+2.46%
at last close
Financials (TTM)
- Revenue
- $239.92 million
- Net Income
- $-205,346,000
- Net Margin
- -85.59%
- Return on Equity
- -199.40%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 70.01
- Price / Sales
- 30.05
Over the trailing twelve months, Rhythm Pharmaceuticals, Inc. Common Stock generated revenue of $239.92 million and net income of $-205,346,000, a net margin of -85.59%.
At the last closing price of $104.71, RYTM trades at 30.05 times sales, with a market capitalization of $7.21 billion.
Key Stats
- Last Close
- $104.71
- Market Cap
- $7.21 billion
- 52-Week Range
- $74.50 – $122.20
- Average Volume
- 590K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.